Literature DB >> 28086100

The Interfaces of Genetic Conflict Are Hot Spots for Innovation.

Joshua Carter1, Connor Hoffman1, Blake Wiedenheft2.   

Abstract

RNA-guided Cas9 endonucleases protect bacteria from viral infection and have been creatively repurposed as programmable molecular scalpels for surgical manipulation of DNA. Now, two papers in Cell (Pawluk et al. and Rauch et al.) identify viral proteins that suppress Cas9 and may function like molecular sheaths for the Cas9 scalpel.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28086100      PMCID： PMC5480287          DOI： 10.1016/j.cell.2016.12.007

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


  8 in total

1.  CRISPR provides acquired resistance against viruses in prokaryotes.

Authors:  Rodolphe Barrangou; Christophe Fremaux; Hélène Deveau; Melissa Richards; Patrick Boyaval; Sylvain Moineau; Dennis A Romero; Philippe Horvath
Journal:  Science       Date:  2007-03-23       Impact factor: 47.728

Review 2.  The phage-host arms race: shaping the evolution of microbes.

Authors:  Adi Stern; Rotem Sorek
Journal:  Bioessays       Date:  2011-01       Impact factor: 4.345

3.  Applications of CRISPR technologies in research and beyond.

Authors:  Rodolphe Barrangou; Jennifer A Doudna
Journal:  Nat Biotechnol       Date:  2016-09-08       Impact factor: 54.908

4.  Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species.

Authors:  April Pawluk; Raymond H J Staals; Corinda Taylor; Bridget N J Watson; Senjuti Saha; Peter C Fineran; Karen L Maxwell; Alan R Davidson
Journal:  Nat Microbiol       Date:  2016-06-13       Impact factor: 17.745

5.  Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins.

Authors:  Joseph Bondy-Denomy; Bianca Garcia; Scott Strum; Mingjian Du; MaryClare F Rollins; Yurima Hidalgo-Reyes; Blake Wiedenheft; Karen L Maxwell; Alan R Davidson
Journal:  Nature       Date:  2015-09-23       Impact factor: 49.962

6.  Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis.

Authors:  Zhonggang Hou; Yan Zhang; Nicholas E Propson; Sara E Howden; Li-Fang Chu; Erik J Sontheimer; James A Thomson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

7.  A new group of phage anti-CRISPR genes inhibits the type I-E CRISPR-Cas system of Pseudomonas aeruginosa.

Authors:  April Pawluk; Joseph Bondy-Denomy; Vivian H W Cheung; Karen L Maxwell; Alan R Davidson
Journal:  mBio       Date:  2014-04-15       Impact factor: 7.867

8.  Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system.

Authors:  Joe Bondy-Denomy; April Pawluk; Karen L Maxwell; Alan R Davidson
Journal:  Nature       Date:  2012-12-16       Impact factor: 49.962
  8 in total
  5 in total

1.  Genome-wide correlation analysis suggests different roles of CRISPR-Cas systems in the acquisition of antibiotic resistance genes in diverse species.

Authors:  Saadlee Shehreen; Te-Yuan Chyou; Peter C Fineran; Chris M Brown
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-13       Impact factor: 6.237

Review 2.  How bacteria control the CRISPR-Cas arsenal.

Authors:  Lina M Leon; Senén D Mendoza; Joseph Bondy-Denomy
Journal:  Curr Opin Microbiol       Date:  2017-11-21       Impact factor: 7.934

Review 3.  Protein Inhibitors of CRISPR-Cas9.

Authors:  Joseph Bondy-Denomy
Journal:  ACS Chem Biol       Date:  2018-01-17       Impact factor: 5.100

4.  Widespread repression of anti-CRISPR production by anti-CRISPR-associated proteins.

Authors:  Saadlee Shehreen; Nils Birkholz; Peter C Fineran; Chris M Brown
Journal:  Nucleic Acids Res       Date:  2022-08-10       Impact factor: 19.160

5.  CRISPR/Cas9: A Potential Life-Saving Tool. What's next?

Authors:  Diana Gulei; Ioana Berindan-Neagoe
Journal:  Mol Ther Nucleic Acids       Date:  2017-11-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.